NATERA, INC. APIC, Share-based Payment Arrangement, Other, Increase for Cost Recognition
NATERA, INC. (NTRA) reported APIC, Share-based Payment Arrangement, Other, Increase for Cost Recognition of $47.03 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Shareholders' Equity › APIC, Share-Based Payment Arrangement, Increase for Cost Recognition
us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationOtherLongtermIncentivePlansRequisiteServicePeriodRecognition · last filed 2026-08-07
- NATERA, INC. apic, share-based payment arrangement, other, increase for cost recognition for the quarter ending 2026-06-30 was $0.00, a 100.00% decline year-over-year.
- NATERA, INC. apic, share-based payment arrangement, other, increase for cost recognition for the quarter ending 2026-03-31 was $47.03M, a 46.67% increase year-over-year.
- NATERA, INC. apic, share-based payment arrangement, other, increase for cost recognition for the quarter ending 2025-12-31 was $0.00.
- NATERA, INC. apic, share-based payment arrangement, other, increase for cost recognition for the quarter ending 2025-09-30 was $0.00.
- NATERA, INC. apic, share-based payment arrangement, other, increase for cost recognition for fiscal 2025 was $32.88M, a 36.58% increase from fiscal 2024.
- NATERA, INC. apic, share-based payment arrangement, other, increase for cost recognition for fiscal 2024 was $24.07M, a 21.73% increase from fiscal 2023.
- NATERA, INC. apic, share-based payment arrangement, other, increase for cost recognition for fiscal 2023 was $19.77M.
| Period end | APIC, Share-based Payment Arrangement, Other, Increase for Cost Recognition 3 month | APIC, Share-based Payment Arrangement, Other, Increase for Cost Recognition 6 month | APIC, Share-based Payment Arrangement, Other, Increase for Cost Recognition 9 month | APIC, Share-based Payment Arrangement, Other, Increase for Cost Recognition 12 month |
|---|---|---|---|---|
| 2026-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-07 | $47.03M 10-Q · filed 2026-08-07 | $47.03M derived: sum of 3 quarters · filed 2026-08-07 | $47.03M derived: sum of 4 quarters · filed 2026-08-07 |
| 2026-03-31 | $47.03M 10-Q · filed 2026-05-08 | $47.03M derived: sum of 2 quarters · filed 2026-05-08 | $47.03M derived: sum of 3 quarters · filed 2026-05-08 | $47.84M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $0.00 derived: sum of 2 quarters · filed 2026-02-27 | $812.00K derived: sum of 3 quarters · filed 2026-08-07 | $32.88M 10-K · filed 2026-02-27 |
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | $812.00K derived: sum of 2 quarters · filed 2026-08-07 | $32.88M 10-Q · filed 2025-11-07 | $32.88M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-06-30 | $812.00K 10-Q · filed 2026-08-07 | $32.88M 10-Q · filed 2026-08-07 | $32.88M derived: sum of 3 quarters · filed 2026-08-07 | $32.88M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-03-31 | $32.06M 10-Q · filed 2026-05-08 | $32.06M derived: sum of 2 quarters · filed 2026-05-08 | $32.06M derived: sum of 3 quarters · filed 2026-05-08 | $32.06M derived: sum of 4 quarters · filed 2026-05-08 |
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $0.00 derived: sum of 2 quarters · filed 2026-02-27 | $0.00 derived: sum of 3 quarters · filed 2026-02-27 | $24.07M 10-K · filed 2026-02-27 |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | $0.00 derived: sum of 2 quarters · filed 2025-11-07 | $24.07M 10-Q · filed 2025-11-07 | $24.07M derived: sum of 4 quarters · filed 2026-02-27 |
| 2024-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-08 | $24.07M 10-Q · filed 2025-08-08 | $24.07M derived: sum of 3 quarters · filed 2026-02-27 | $24.07M derived: sum of 4 quarters · filed 2026-02-27 |
| 2024-03-31 | $24.07M 10-Q · filed 2025-05-09 | $24.07M derived: sum of 2 quarters · filed 2026-02-27 | $24.07M derived: sum of 3 quarters · filed 2026-02-27 | $24.07M derived: sum of 4 quarters · filed 2026-02-27 |
| 2023-12-31 | $3.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $3.00K derived: sum of 2 quarters · filed 2026-02-27 | $3.00K derived: sum of 3 quarters · filed 2026-02-27 | $19.77M 10-K · filed 2026-02-27 |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | $0.00 derived: sum of 2 quarters · filed 2024-11-12 | $19.77M 10-Q · filed 2024-11-12 | |
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-09 | $19.77M 10-Q · filed 2024-08-09 | ||
| 2023-03-31 | $19.77M 10-Q · filed 2024-05-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| QUEST DIAGNOSTICS INC (DGX) | United States | $26.096B | 22.09 |
| LABCORP HOLDINGS INC. (LH) | United States | $25.060B | 22.60 |
| Guardant Health, Inc. (GH) | United States | $23.675B | -12.65 |
| Caris Life Sciences, Inc. (CAI) | United States | $9.119B | 47.87 |
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| VERACYTE, INC. (VCYT) | United States | $3.904B | 41.21 |
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |